AAAAAA

   
Results: 1-19 |
Results: 19
A chimeric MIP-1 alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors
Authors: Blanpain, C Buser, R Power, CA Edgerton, M Buchanan, C Mack, M Simmons, G Clapham, PR Parmentier, M Proudfoot, AEI
Citation: C. Blanpain et al., A chimeric MIP-1 alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors, J LEUK BIOL, 69(6), 2001, pp. 977-985
CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin
Authors: Reiss, Y Proudfoot, AE Power, CA Campbell, JJ Butcher, EC
Citation: Y. Reiss et al., CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin, J EXP MED, 194(10), 2001, pp. 1541-1547
Factors that influence T helper cell response to infection
Authors: Power, CA
Citation: Ca. Power, Factors that influence T helper cell response to infection, CURR OPIN I, 13(3), 2000, pp. 209-213
Evaluation of the reveal and SafePath rapid Escherichia coli O157 detection tests for use on bovine feces and carcasses
Authors: Power, CA Johnson, RP McEwen, SA McNab, WB Griffiths, MW Usborne, WR De Grandis, SA
Citation: Ca. Power et al., Evaluation of the reveal and SafePath rapid Escherichia coli O157 detection tests for use on bovine feces and carcasses, J FOOD PROT, 63(7), 2000, pp. 860-866
The strategy of blocking the chemokine system to combat disease
Authors: Proudfoot, AEI Power, CA Wells, TNC
Citation: Aei. Proudfoot et al., The strategy of blocking the chemokine system to combat disease, IMMUNOL REV, 177, 2000, pp. 246-256
International union of pharmacology. XXII. Nomenclature for chemokine receptors
Authors: Murphy, PM Baggiolini, M Charo, IF Hebert, CA Horuk, R Matsushima, K Miller, LH Oppenheim, JJ Power, CA
Citation: Pm. Murphy et al., International union of pharmacology. XXII. Nomenclature for chemokine receptors, PHARM REV, 52(1), 2000, pp. 145-176
A key role for CC chemokine receptor 4 in lipopolysaccharide-induced endotoxic shock
Authors: Chvatchko, Y Hoogewerf, AJ Meyer, A Alouani, S Juillard, P Buser, R Conquet, F Proudfoot, AEI Wells, TNC Power, CA
Citation: Y. Chvatchko et al., A key role for CC chemokine receptor 4 in lipopolysaccharide-induced endotoxic shock, J EXP MED, 191(10), 2000, pp. 1755-1763
Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets
Authors: Clemetson, KJ Clemetson, JM Proudfoot, AEI Power, CA Baggiolini, M Wells, TNC
Citation: Kj. Clemetson et al., Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets, BLOOD, 96(13), 2000, pp. 4046-4054
Generation of stable cell lines expressing chemokine receptors
Authors: Power, CA Meyer, A
Citation: Ca. Power et A. Meyer, Generation of stable cell lines expressing chemokine receptors, METH MOL B, 138, 2000, pp. 99-104
Chemokine analogues
Authors: Proudfoot, AEI Power, CA Wells, T
Citation: Aei. Proudfoot et al., Chemokine analogues, CHEMOKINES IN ALLERGIC DISEASE, 2000, pp. 509-532
Effects of CCR4 knockout in a mouse model of lung inflammation
Authors: Power, CA
Citation: Ca. Power, Effects of CCR4 knockout in a mouse model of lung inflammation, EUR CYTOKIN, 10(2), 1999, pp. 296-297
Chemokine receptors and their role in leukocyte activation
Authors: Wells, TNC Proudfoot, AEI Power, CA
Citation: Tnc. Wells et al., Chemokine receptors and their role in leukocyte activation, IMMUNOL LET, 65(1-2), 1999, pp. 35-40
Enhancement of human immunodeficiency virus type 1 infection by the CC-chemokine RANTES is independent of the mechanism of virus-cell fusion
Authors: Gordon, CJ Muesing, MA Proudfoot, AEI Power, CA Moore, JP Trkola, A
Citation: Cj. Gordon et al., Enhancement of human immunodeficiency virus type 1 infection by the CC-chemokine RANTES is independent of the mechanism of virus-cell fusion, J VIROLOGY, 73(1), 1999, pp. 684-694
A valid ELISPOT assay for enumeration of ex vivo, antigen-specific, IFN gamma-producing T cells
Authors: Power, CA Grand, CL Ismail, N Peters, NC Yurkowski, DP Bretscher, PA
Citation: Ca. Power et al., A valid ELISPOT assay for enumeration of ex vivo, antigen-specific, IFN gamma-producing T cells, J IMMUNOL M, 227(1-2), 1999, pp. 99-107
A member of the dendritic cell family that enters B cell follicles and stimulates primary antibody responses identified by a mannose receptor fusion protein
Authors: Berney, C Herren, S Power, CA Gordon, S Martinez-Pomares, L Kosco-Vilbois, MH
Citation: C. Berney et al., A member of the dendritic cell family that enters B cell follicles and stimulates primary antibody responses identified by a mannose receptor fusion protein, J EXP MED, 190(6), 1999, pp. 851-860
Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors
Authors: Proudfoot, AEI Buser, R Borlat, F Alouani, S Soler, D Offord, RE Schroder, JM Power, CA Wells, TNC
Citation: Aei. Proudfoot et al., Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors, J BIOL CHEM, 274(45), 1999, pp. 32478-32485
Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses
Authors: Kuschert, GSV Coulin, F Power, CA Proudfoot, AEI Hubbard, RE Hoogewerf, AJ Wells, TNC
Citation: Gsv. Kuschert et al., Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses, BIOCHEM, 38(39), 1999, pp. 12959-12968
Chemokines in rheumatoid arthritis
Authors: Plater-Zyberk, C Vencovsky, L Power, CA
Citation: C. Plater-zyberk et al., Chemokines in rheumatoid arthritis, CONT IMMUN, 8, 1999, pp. 151-158
Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route
Authors: Power, CA Wei, GJ Bretscher, PA
Citation: Ca. Power et al., Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route, INFEC IMMUN, 66(12), 1998, pp. 5743-5750
Risultati: 1-19 |